State Biosimilar Bills Pose New Threat To Budding Industry
Spurred by safety concerns from brand-name drugmakers, state legislators around the country are proposing to restrict patient access to generic versions of pricey biologic medicines, posing a threat to the fledgling...To view the full article, register now.
Already a subscriber? Click here to view full article